For Rapid & Sustained Gastric Protection
℞ - Pantoprazole Tablets IP 40 mg
Pantopax® 40 contains Pantoprazole, a proton pump inhibitor (PPI) that provides effective and long-lasting suppression of gastric acid secretion. It is indicated for acid-related gastrointestinal disorders requiring reliable symptom control and mucosal healing.
- Gastroesophageal reflux disease (GERD)
- Erosive esophagitis
- Peptic ulcer disease
- Zollinger–Ellison syndrome
- NSAID-induced gastric irritation
- Acid-related dyspepsia
Pantopax® 40 is designed to deliver consistent acid suppression through targeted inhibition of the gastric proton pump. It is widely used in the management of reflux disease, peptic ulcer disorders, and other conditions associated with excessive gastric acid secretion.
Why Pantopax® 40
◉ Provides rapid onset with sustained gastric acid suppression
◉ Maintains consistent acid control over 24 hours
◉ Supports healing and relapse prevention in ulcer disease
◉ Suitable for maintenance therapy under medical supervision
◉ Established standard of care in acid-related disorders
Mechanism of Action
Pantopax® 40 provides targeted acid control through:
◉ Pantoprazole
Irreversibly inhibits the gastric H⁺/K⁺-ATPase (proton pump) in parietal cells, thereby reducing both basal and stimulated gastric acid secretion.
Key Clinical Advantages
◉ Once-daily dosing for improved patient compliance
◉ Consistent acid suppression over 24 hours
◉ Supports ulcer healing and relapse prevention
◉ Suitable for long-term maintenance therapy under supervision
◉ Widely accepted and trusted PPI in clinical practice
Dosage & Administration
Dosage:
As directed by the physician.
Administration:
Preferably taken after meals.
Schedule H Prescription Drug – Caution
Not to be sold by retail without the prescription of a Registered Medical Practitioner.
